Ibnsina Pharma reported earnings results for the first quarter of 2020. The company reported 19.76% year-on-year (YoY) increase in its net profits to EGP 50.27 million in the first quarter of 2020, compared to EGP 41.97 million. The company's sales rose to EGP 4.55 billion in the first three months of 2020 from EGP 3.8 billion in the year-ago period.